Trial intelligence / Profile preview

Intranasal fluticasone propionate in bilateral nasal polyposis

2011-004886-34Phase 3Completed

Sponsor
OptiNose
Start
Jul 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of fluticasone and fluticasone propionate in chronic rhinosinusitis with nasal polyps (CRSwNP) and nasal polyp (4 arms), sponsored by OptiNose. Started Jul 2012; status: completed.

02

Drugs

fluticasonefluticasone propionate
03

Conditions

chronic rhinosinusitis with nasal polyps (CRSwNP)nasal polyp

Beyond the preview

Go deeper on 2011-004886-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-004886-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call